homocysteine and Granulocytic Leukemia, Chronic, Stable Phase

homocysteine has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balsat, M; Bert, A; Blond, E; Drai, J; Escoffre-Barbe, M; Etienne, G; Etienne, M; Fossard, G; Giraudier, S; Heiblig, M; Labussière-Wallet, H; Lega, JC; Mahon, FX; Morisset, S; Nicolini, FE; Redonnet-Vernhet, I; Sobh, M	1

Other Studies

1 other study(ies) available for homocysteine and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients. Haematologica, 2016, Volume: 101, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cholesterol, HDL; Coronary Artery Disease; Drug Administration Schedule; Female; Homocysteine; Humans; Hyperhomocysteinemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prospective Studies; Pyrimidines; Retrospective Studies; Triglycerides	2016

Article

Year

Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients.

Haematologica, 2016, Volume: 101, Issue:3

Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cholesterol, HDL; Coronary Artery Disease; Drug Administration Schedule; Female; Homocysteine; Humans; Hyperhomocysteinemia; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prospective Studies; Pyrimidines; Retrospective Studies; Triglycerides

2016